Abstract
BACKGROUND: Fragile x syndrome is caused by loss of expression of the FMRP protein involved in the control of a large number of mRNA targets. The Drosophila ortholog dFXR interacts with a protein complex that includes Argonaute2, an essential component of the RNA-induced silencing complex (RISC). Furthermore dFXR associates with Dicer, another essential processing enzyme of the RNAi pathway. Both microRNA and microRNA precursors can co-immunoprecipitate with dFXR. Consequently it has been suggested that the Fragile x syndrome may be due to a defect in an RNAi-related apparatus.
FINDINGS: We have investigated the RNAi response in Fragile x patient cells lacking FMRP compared with normal controls. RNAi responses were successfully detected, but no statistically significant difference between the response in normal cells compared to patients cells was found - neither one nor two days after transfection.
CONCLUSION: Our data show that in human fibroblasts from Fragile x patients lacking FMRP the RNAi response is not significantly impaired.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | BMC Research Notes |
| Vol/bind | 2 |
| Sider (fra-til) | 177 |
| ISSN | 1756-0500 |
| DOI | |
| Status | Udgivet - 9 sep. 2009 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Normal RNAi response in human fragile x fibroblasts'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS